KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 121 filers reported holding KYMERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $518,887 | -52.5% | 37,330 | -21.4% | 0.00% | 0.0% |
| Q2 2023 | $1,091,542 | +4.3% | 47,479 | +34.4% | 0.00% | 0.0% |
| Q1 2023 | $1,046,858 | +30.0% | 35,331 | +9.5% | 0.00% | 0.0% |
| Q4 2022 | $805,335 | +16.9% | 32,265 | +2.1% | 0.00% | 0.0% |
| Q3 2022 | $689,000 | +50.8% | 31,608 | +36.0% | 0.00% | – |
| Q2 2022 | $457,000 | -53.7% | 23,244 | -0.3% | 0.00% | -100.0% |
| Q1 2022 | $987,000 | -20.5% | 23,305 | +19.1% | 0.00% | 0.0% |
| Q4 2021 | $1,242,000 | +27.4% | 19,570 | +17.9% | 0.00% | 0.0% |
| Q3 2021 | $975,000 | +200.9% | 16,597 | +148.0% | 0.00% | – |
| Q2 2021 | $324,000 | -14.7% | 6,691 | -31.6% | 0.00% | – |
| Q1 2021 | $380,000 | -43.9% | 9,784 | -10.4% | 0.00% | – |
| Q4 2020 | $677,000 | – | 10,917 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |